| |
|
|
|
|
|
|
|||
|
Blood, 15 September 2006, Vol. 108, No. 6, pp. 2121-2123. Prepublished online as a Blood First Edition Paper on May 30, 2006; DOI 10.1182/blood-2006-03-013599.
TRANSPLANTATION Short-term repopulating cells with myeloid potential in human mobilized peripheral blood do not have a side population (SP) phenotypeFrom the Department of Internal Medicine I, Albert-Ludwigs-University, Freiburg, Germany; the Faculty of Biology, Albert-Ludwigs-University, Freiburg, Germany; the Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University, Freiburg, Germany; the Terry Fox Laboratory, British Columbia Cancer Agency, University of British Columbia, Vancouver, Canada; the Department of Medical Genetics, University of British Columbia, Vancouver, Canada; the National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany; and the Experimental Hematology Research Foundation, Molecular and Gene Therapy Program, Cincinnati Children's Hospital, OH.
Clinical use of purified hematopoietic stem cells in myeloablated patients requires cotransplantation of short-term repopulating cells (STRCs) to ensure timely count recovery. Here, we investigated the flow fluorescence-based side population (SP) phenotype of mobilized human peripheral blood (mPB) cells that rapidly repopulate the highly permissive nonobese diabetic/severe combined immunodeficient (NOD/SCID)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||